Bullish Case: Strong Q4 2023 performance with record non-IFRS metrics, continued revenue growth, and positive guidance affirm Celestica's upward trajectory.


Bearish Case: Geopolitical risks or legislative changes affecting taxes could erode profits and market sentiment, leading to stock underperformance.


Potential Outcomes:

1. Continued growth and market-beating performance (65%).

2. Policy shifts provoke market revaluation (20%).

3. Sudden geopolitical events disrupt supply (15%).


Trading Oracle: Sign Up to access trading oracle trade ideas.


February 21, 2024


Celestica Forecast

[CLS]  Celestica
Price Forecast: BULLISH    Price Action: MEAN REVERTING (?)



Make More Profitable Trades with CLS Forecasts + Trading Strategies







CLS Balanced News:
















Correlated Stock Forecasts

Assets that tend to move strongly with CLS



ANF Forecast + Options Trading Strategies   [ANF]  Abercrombie & Fitch (0.99)


INFA Forecast + Options Trading Strategies   [INFA]  Informatica (0.98)


SPLK Forecast + Options Trading Strategies   [SPLK]  Splunk (0.97)


NTNX Forecast + Options Trading Strategies   [NTNX]  Nutanix (0.97)


WSM Forecast + Options Trading Strategies   [WSM]  Williams-Sonoma (0.97)



Uncorrelated Stock Forecasts

Assets with little price relationship to CLS



CPA Forecast + Options Trading Strategies   [CPA]  Copa (-0.0)


CPG Forecast + Options Trading Strategies   [CPG]  Crescent Point Energy (-0.0)


VIRT Forecast + Options Trading Strategies   [VIRT]  Virtu Financial (-0.01)


ROBO Forecast + Options Trading Strategies   [ROBO]  Exchange Traded Concepts Trust - ETCT ROBO Global Robotics and Automation Index (-0.01)


CYTK Forecast + Options Trading Strategies   [CYTK]  Cytokinetics (-0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against CLS



YUMC Forecast + Options Trading Strategies   [YUMC]  Yum China (-0.93)


UVXY Forecast + Options Trading Strategies   [UVXY]  ProShares Ultra VIX Short-Term Futures (-0.93)


BMY Forecast + Options Trading Strategies   [BMY]  Bristol-Myers Squibb (-0.93)


STAA Forecast + Options Trading Strategies   [STAA]  Staar Surgical (-0.95)


RVNC Forecast + Options Trading Strategies   [RVNC]  Revance Therapeutics (-0.95)


CLS News over Time





Click points to explore news by date. News sentiment ranges from -10 (very negative) to +10 (very positive) where 0 is neutral.

Most Recent CLS News






Become a more profitable investor with AI optimized trading strategies






×

Chat with Helium


 Ask me any question!